N@N

FORT LAUDERDALE, Fla.--([ BUSINESS WIRE ])--Imaging Diagnostic Systems, Inc., (OTCBB:IMDS), a pioneer in laser optical breast imaging announced today that it has signed an exclusive agreement with ID Matrix Systems as its new distribution partner for all of China. ID-Matrix Systems will market and sell the CTLM system to private and government hospitals and private imaging centers throughout China and Hong Kong.

"China is a highly desirable territory due to its large population, growing economy and its demand for innovative technologies. This agreement requires ID-Matrix to order a minimum of 15 CTLM systems within the first year of the contract along with a 50% deposit with each order to remain as the company's exclusive distributor. We are hopeful that ID-Matrix will be successful in promoting and marketing the CTLM system resulting in it becoming one of the leading breast imaging technology throughout China," stated Linda Grable/CEO Imaging Diagnostic Systems.

About Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and shows the process of angiogenesis, which usually accompanies tumor growth. CTLM system has received international certifications and licenses from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL, and ISO 13485. The Company is seeking FDA approval through the Premarket approval process.

For more information, visit our website: [ www.imds.com ]

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Companyas filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.